Sema4 (NASDAQ:SMFR – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued to investors on Tuesday, Zacks.com reports. According to Zacks, “Sema4 Holdings Corp is a patient-centered health intelligence company. It is transforming healthcare by applying AI and machine learning to multidimensional, longitudinal […]
Sema4 Holdings Corp (NASDAQ:SMFR – Get Rating)’s stock price traded down 6.2% during trading on Monday . The company traded as low as $2.81 and last traded at $2.89. 76,128 shares were traded during trading, a decline of 96% from the average session volume of 1,707,424 shares. The stock had previously closed at $3.08. Several […]
Sema4 (NASDAQ:SMFR – Get Rating) announced its earnings results on Monday. The company reported ($0.17) earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.26) by $0.09, MarketWatch Earnings reports. Sema4 updated its FY 2022 guidance to EPS. NASDAQ SMFR traded up $0.05 during mid-day trading on Tuesday, hitting $2.70. The […]
Skip to main content
Currently Reading A validation of mission and strategy : The pandemic hasn t stopped Annie Lamont s Oak HC/FT from making major investments
FacebookTwitterEmail
1of8
Oak HC/FT co-founders and managing partners Andrew Adams, left, Patricia Kemp, center, and Annie Lamont pose outside the Oak HC/FT office at Pickwick Plaza in Greenwich, Conn., on Monday, March 8, 2021. The Greenwich-based venture capital firm invests in early to growth-stage health care and financial technology companies.Tyler Sizemore / Hearst Connecticut MediaShow MoreShow Less
2of8
Oak HC/FT co-founders and managing partners Andrew Adams, left, Patricia Kemp, center, and Annie Lamont pose outside the Oak HC/FT office at Pickwick Plaza in Greenwich, Conn., on Monday, March 8, 2021. The Greenwich-based venture capital firm invests in early to growth-stage health care and financial technology companies.Tyler Sizemore / Hearst Connecticut MediaShow MoreShow Less
The right scale of fuel : Stamford-based Sema4 eyes more growth by going public
FacebookTwitterEmail
State Rep. Matt Blumenthal, at left, and Sen. Chris Murphy, at center, tour Sema4 s laboratory at 62 Southfield Ave., in Stamford, Conn., on Sept. 18, 2020.Matthew Brown / Hearst Connecticut Media
STAMFORD Health care information provider Sema4 announced Wednesday that it would become a publicly traded company, an ambitious plan intended to catalyze further growth for one of the fastest-expanding firms in Connecticut.
In a move that values the company at approximately $2 billion, Stamford-headquartered Sema4 is going public through a process that offers an alternative to an initial public offering. It would result in Sema4’s shares trading on the Nasdaq Global Market upon the transaction’s expected completion in the second quarter of this year.